Rat OPN quantitates rat OPN in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat OPN.
Accession number
2 AR ; 2b7 ; 44 kDa phosphoprotéine osseuse ; Apl-1 ; BNSP ; Bone sialoprotéine 1 ; Bsp ; BSPI ; protéine inhibiteur de croissance du cristal d’oxalate de calcium ; activation précoce des lymphocytes T 1 ; protéine d’activation précoce des lymphocytes T 1 ; Eta ; HAP-1 ; HGNC:11255 ; MGC110940 ; Minopontin; nephropontine; OP; Opn; Opnl; OSP; ostéopontine; ostéopontine/immunoglobuline alpha 1 protéine de fusion de région constante à chaîne lourde; protéine semblable à l’ostéopontine; PSEC0156; Ric; phosphoprotéine sectée 1; Phosphoprotéine 1 sécrétée (ostéopontine, sialoprotéine I osseuse, activation précoce des lymphocytes T 1); phosphoprotéine sécrétée 1 variante 6; sialoprotéine (ostéopontine); Spp1; SPP-1; fusion SPP1/Calpha1; Produit protéique sans nom ; urinar ; protéine de pierre urinaire ; U-pontine
Dose range
80 to 20 000 pg/ml
Sensitivity of the dosage
80 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Rat OPN quantitates rat OPN in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat OPN.
Rat OPN quantitates rat OPN in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat OPN.
The osteopontin is a glycoprotein containing arginine-glycin-aspartic acid (RGD) that interacts with integrins and CD44 as major receptors. It is a multifunctional protein involved in bone mineralization, cell adhesion, cell migration, chronic inflammatory diseases and transformation. The proteolytic cleavage by thrombin and matrix metalloproteinases close to the Arg-Gly-Asp sequence binding to integrin modulus the function of the OPN and its integrin binding properties. The cleavage thrombin fragments of l的osteopontin are overexpressed in malignant glial tumours and provide a molecular niche with a survival advantage and provide a new substrate for plasmine and cathepsin D.
Sensitivity
Sensitivity of dosage: 80 pg/ml.
Measurement range
Dose range: 80 to 20,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Osteopontine.
Samples
Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17125063
Specifications
Accession number
2 AR; 2b7; 44 kDa bone phosphoprotein; Apl-1; BNSP; Bone sialoprotein 1; Bsp; BSPI; calcium crystal-inhibitor protein; early activation of T 1 lymphocytes; early activation of T 1 lymphocytes; Eta; HAP-1; HGNC:11255; MGC110940; Min